Investor Stock List
Ranked #3,640 of 8,699 institutional investors

Tri Locum Partners LP

New York, NY

$498M
US stock portfolio at live prices · today −$293K (−0.06%)
Live prices, last trade 10:55 AM ET
Value at quarter end (Q3 2026)
$506M
Change from Q2 2026
−$307.1M (−37.76%)
Positions
15 · 3 new, 4 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$113M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
VRTX 14.0%LLY 13.9%AMRX 9.97%DXCM 7.88%ARGX 5.73%
StockSharesValue, live% of portfoliovs Q2 2026
VRTX Vertex Pharmaceuticals Incorporated132,896$69.8M14.0%Reduced −34%
LLY Eli Lilly and Company51,015$69.3M13.9%Reduced −33%
AMRX Amneal Pharmaceuticals, Inc.2,326,733$49.7M9.97%New
DXCM DexCom, Inc.489,400$39.2M7.88%Reduced −40%
ARGX argenx SE30,399$28.5M5.73%Reduced −27%
JNJ Johnson & Johnson73,559$20.0M4.02%Reduced −83%
ELVN Enliven Therapeutics, Inc.410,236$19.2M3.86%Reduced −53%
AXSM Axsome Therapeutics, Inc.143,338$18.8M3.78%Reduced −35%
UTHR United Therapeutics Corporation33,000$18.3M3.67%Reduced −30%
DNTH Dianthus Therapeutics, Inc.177,225$14.7M2.96%Added +47%
MDGL Madrigal Pharmaceuticals, Inc.33,668$13.1M2.64%Reduced −51%
CELC Celcuity Inc.202,618$11.1M2.24%New
RVMD Revolution Medicines, Inc.40,019$6.6M1.33%Reduced −74%
DFTX Definium Therapeutics, Inc.144,406$4.2M0.85%Reduced −11%
VRDN Viridian Therapeutics, Inc.90,107$2.8M0.56%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
TARS Tarsus Pharmaceuticals, Inc.328,340$24.6M
ISRG Intuitive Surgical, Inc.47,983$19.4M
CYTK Cytokinetics, Incorporated194,000$10.2M
BBNX Beta Bionics, Inc.493,344$6.7M